In contrast to their conclusion, our study demonstrated that ablation of IL-21R impeded liver cancer development, particularly MASH-driven HCC, in two different mouse models of spontaneous MASH-driven HCC: the STAM model and the WD&High sugar solution&CCl4 model. The gene discussed is IL21R; the disease is hepatocellular carcinoma.